Arvinas Ownership | Who Owns Arvinas?
Arvinas Ownership Summary
Arvinas is owned by 95.88% institutional investors, 6.85% insiders. Vanguard group is the largest institutional shareholder, holding 9.80% of ARVN shares. BB Biotech AG Ord is the top mutual fund, with 3.46% of its assets in Arvinas shares.
ARVN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Arvinas | 95.88% | 6.85% | -2.73% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Vanguard group | 7.06M | 9.80% | $135.39M |
Blackrock funding, inc. /de | 6.89M | 9.46% | $50.71M |
Blackrock | 6.26M | 8.70% | $166.61M |
Price t rowe associates inc /md/ | 4.10M | 5.69% | $78.66M |
Pfizer | 3.46M | 4.75% | $25.45M |
Logos global management lp | 3.30M | 4.53% | $24.29M |
Ubs group | 2.04M | 2.83% | $39.08M |
Jpmorgan chase | 1.86M | 2.58% | $35.60M |
State street | 1.64M | 2.28% | $31.38M |
Opaleye management | 1.63M | 2.25% | $33.64M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
New leaf venture partners | 1.59M | 22.04% | $11.67M |
Aquilo capital management | 328.77K | 9.50% | $6.30M |
Opaleye management | 1.63M | 5.89% | $33.64M |
Pfizer | 3.46M | 4.42% | $25.45M |
Nextech invest | 1.41M | 4.38% | $27.00M |
Logos global management lp | 3.30M | 2.69% | $24.29M |
22nw, lp | 413.53K | 1.92% | $3.04M |
Ikarian capital | 850.00K | 1.20% | $6.26M |
Monaco asset management sam | 900.94K | 1.16% | $6.63M |
Boxer capital | 608.61K | 0.85% | $16.20M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Logos global management lp | 3.30M | 2.69% | 3.30M |
Ubs group | 2.04M | 0.01% | 1.57M |
Caption management | 1.34M | 0.11% | 1.28M |
Acadian asset management | 1.43M | 0.02% | 1.27M |
Norges bank | 1.24M | 0.00% | 1.24M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ecor1 capital | - | - | -6.73M |
Rtw investments, lp | - | - | -3.33M |
Bellevue group | - | - | -2.39M |
Paradigm biocapital advisors lp | - | - | -2.34M |
Alyeska investment group | - | - | -1.80M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 1.24M | 0.00% | 1.24M | $23.84M |
Armistice capital | 560.00K | 0.07% | 560.00K | $4.12M |
22nw, lp | 413.53K | 1.92% | 413.53K | $3.04M |
Y-intercept (hong kong) | 145.75K | 0.03% | 145.75K | $1.07M |
Connor, clark & lunn investment management | 86.20K | 0.00% | 86.20K | $634.45K |
Sold Out
Holder | Change |
---|---|
Capital performance advisors llp | -6.00 |
Smartleaf asset management | -8.00 |
Cornerstone planning group | -17.00 |
Capital advisors | -28.00 |
Avion wealth | -33.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 229 | 1.33% | 69,799,900 | 12.46% | 95 | 1.31% | 130 | 2.36% | 52 | -10.34% |
Mar 31, 2025 | 227 | 7.08% | 64,055,484 | -16.35% | 88 | 0.78% | 127 | 13.39% | 58 | 13.73% |
Dec 31, 2024 | 208 | -4.59% | 76,287,067 | 7.32% | 105 | 1.09% | 111 | 9.90% | 51 | -22.73% |
Sep 30, 2024 | 217 | 3.33% | 71,015,986 | 0.13% | 98 | 1.01% | 99 | -18.18% | 67 | 26.42% |
Jun 30, 2024 | 210 | -7.89% | 70,926,259 | 4.97% | 98 | 1.11% | 121 | - | 53 | -18.46% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
BB Biotech AG Ord | 2.38M | 3.46% | - |
Vanguard US Total Market Shares ETF | 1.93M | 2.81% | 2.43K |
Vanguard Total Stock Mkt Idx Inv | 2.01M | 2.75% | -44.64K |
iShares Russell 2000 ETF | 1.56M | 2.14% | -29.71K |
Vanguard Explorer Inv | 1.56M | 2.13% | 683.33K |
Vanguard Strategic Equity Inv | 1.25M | 1.71% | 594.88K |
Vanguard Small Cap Index | 841.18K | 1.15% | -5.64K |
JPMorgan Small Cap Growth A | 755.08K | 1.10% | -8.49K |
T. Rowe Price Small-Cap Stock | 702.69K | 1.02% | 94.70K |
Vanguard Institutional Extnd Mkt Idx Tr | 747.55K | 1.02% | -326.16K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Sep 22, 2025 | Morrison Briggs | - | Buy | $227.01K |
Jun 24, 2025 | Saik Andrew | Chief Financial Officer | Sell | $43.38K |
Jun 17, 2025 | Cacace Angela M | Chief Scientific Officer | Sell | $19.35K |
Mar 18, 2025 | Berkowitz Noah | Chief Medical Officer | Sell | $74.37K |
Feb 24, 2025 | Loomis David K | Chief Accounting Officer | Sell | $20.33K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | 1 | - |
2025 Q2 | - | 2 |
2025 Q1 | - | 8 |
2024 Q4 | - | 1 |
2024 Q2 | - | - |
ARVN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools